Enumerative Discovery of Noncanonical Polypeptide Secondary Structures Publications 2024 Enumerative Discovery of Noncanonical Polypeptide Secondary Structures
Drugs from drugs: New chemical insights into a mature concept Publications 2024 Drugs from drugs: New chemical insights into a mature concept
From canonical to unique: extension of a lipophilicity scale of amino acids to non-standard residues Publications 2024 From canonical to unique: extension of a lipophilicity scale of amino acids to non-standard residues
Binding of Cholesterol to the N-Terminal Domain of the NPC1L1 Transporter: Analysis of the Epimerization-Related Binding Selectivity and Loop Mutations Publications 2024 Binding of Cholesterol to the N-Terminal Domain of the NPC1L1 Transporter: Analysis of the Epimerization-Related Binding Selectivity and Loop Mutations
Influenza A virus hemagglutinin: from classical fusion inhibitors to proteolysis targeting chimera-based strategies in antiviral drug discovery Publications 2024 Influenza A virus hemagglutinin: from classical fusion inhibitors to proteolysis targeting chimera-based strategies in antiviral drug discovery
Acetylcholinesterase: A Versatile Template to Coin Potent Modulators of Multiple Therapeutic Targets Publications 2024 Acetylcholinesterase: A Versatile Template to Coin Potent Modulators of Multiple Therapeutic Targets
Quantum mechanical-based strategies in drug discovery: Finding the pace to new challenges in drug design Publications 2024 Quantum mechanical-based strategies in drug discovery: Finding the pace to new challenges in drug design
On the relevance of query definition in the performance of 3D ligand-based virtual screening Publications 2024 On the relevance of query definition in the performance of 3D ligand-based virtual screening
Validation of a highly sensitive HaloTag-based assay to evaluate the potency of a novel class of allosteric β-Galactosidase correctors Publications 2023 Validation of a highly sensitive HaloTag-based assay to evaluate the potency of a novel class of allosteric β-Galactosidase correctors
GT-02287, a brain-penetrant structurally targeted allosteric regulator for glucocerebrosidase show evidence of pharmacological efficacy in models of Parkinson’s disease Publications 2023 GT-02287, a brain-penetrant structurally targeted allosteric regulator for glucocerebrosidase show evidence of pharmacological efficacy in models of Parkinson’s disease